Michael Nohaile
CIK: 0001890563
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FLGT
Fulgent Genetics, Inc.
Director
Discretionary Trading P&L
Holdings
About Nohaile Michael
Nohaile Michael (SEC CIK 0001890563) files insider reports with the SEC as Director of Fulgent Genetics, Inc. (FLGT).
Signal8 holds 2 ownership filings by Nohaile Michael, all Form 4s, filed between May 19, 2025 and May 18, 2026. Those filings report 2 transactions, from May 15, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nohaile Michael's filings is in EL MONTE, CA.
Recent filings by Nohaile Michael
Other insiders filing for Fulgent Genetics, Inc. (FLGT)
- Gao Hanlin, Chief Scientific Officer
- Xie Jian, President and COO
- Kim Paul, CFO and Treasurer
- Hsieh Ming, Chief Executive Officer
- Dong Linda, Director
- GROVES REGINA E, Director